Cargando…

Antidepressant-withdrawal mania - a case report

INTRODUCTION: An uncommon adverse event of antidepressant discontinuation is the paradoxical withdrawal hypomania or mania. It is rarely described in the literature and its true incidence is unknown, may it be a consequence of underrecognition or misattribution. OBJECTIVES: Alert clinicians of the u...

Descripción completa

Detalles Bibliográficos
Autores principales: Magalhães, M., Moreno, L., Mendes, R., Gamito, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9528443/
http://dx.doi.org/10.1192/j.eurpsy.2021.543
_version_ 1784801297523802112
author Magalhães, M.
Moreno, L.
Mendes, R.
Gamito, A.
author_facet Magalhães, M.
Moreno, L.
Mendes, R.
Gamito, A.
author_sort Magalhães, M.
collection PubMed
description INTRODUCTION: An uncommon adverse event of antidepressant discontinuation is the paradoxical withdrawal hypomania or mania. It is rarely described in the literature and its true incidence is unknown, may it be a consequence of underrecognition or misattribution. OBJECTIVES: Alert clinicians of the uncommon Antidepressant-Withdrawal Mania METHODS: Report and discuss, based on online pubmed database, a case of Antidepressant-Withdrawal Mania with Citalopram RESULTS: A 34 year old woman, with a previous unipolar depressive episode, presents to the emergency department in june/2020 with anxiety, recurrent thoughts of death without a plan, low energy, anhedonia, loss of appetite, sadness and insomnia developing over a period of 7 months. She was prescribed Quetiapine 50 mg XR, Lamotrigine 100 mg, and sent to a psychiatry consultation. After a month and a half there was no important clinical improvement and Citalopram 20 mg was started. The patient reported slow improvement and by august she had a complete symptomatic response. In the beginning of september the patient stopped citalopram abruptly. Three weeks later, she was presented with an irritable mood, increased energy with decreased need for sleep, sweet cravings, easy irritability, racing thoughts, pressure to keep talking and suicidal thoughts. After 2 weeks of Quetiapine 300 mg XR id, Lamotrigine 100 mg id and Olanzapine 5 mg there was a partial symptomatic response. CONCLUSIONS: Antidepressant withdrawal manic states are an under-recognized phenomena, with ill defined patho-physiological pathways and nosology. It is important to continue close follow up of the patient and to investigate whether it can be included on the bipolar spectrum.
format Online
Article
Text
id pubmed-9528443
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-95284432022-10-17 Antidepressant-withdrawal mania - a case report Magalhães, M. Moreno, L. Mendes, R. Gamito, A. Eur Psychiatry Abstract INTRODUCTION: An uncommon adverse event of antidepressant discontinuation is the paradoxical withdrawal hypomania or mania. It is rarely described in the literature and its true incidence is unknown, may it be a consequence of underrecognition or misattribution. OBJECTIVES: Alert clinicians of the uncommon Antidepressant-Withdrawal Mania METHODS: Report and discuss, based on online pubmed database, a case of Antidepressant-Withdrawal Mania with Citalopram RESULTS: A 34 year old woman, with a previous unipolar depressive episode, presents to the emergency department in june/2020 with anxiety, recurrent thoughts of death without a plan, low energy, anhedonia, loss of appetite, sadness and insomnia developing over a period of 7 months. She was prescribed Quetiapine 50 mg XR, Lamotrigine 100 mg, and sent to a psychiatry consultation. After a month and a half there was no important clinical improvement and Citalopram 20 mg was started. The patient reported slow improvement and by august she had a complete symptomatic response. In the beginning of september the patient stopped citalopram abruptly. Three weeks later, she was presented with an irritable mood, increased energy with decreased need for sleep, sweet cravings, easy irritability, racing thoughts, pressure to keep talking and suicidal thoughts. After 2 weeks of Quetiapine 300 mg XR id, Lamotrigine 100 mg id and Olanzapine 5 mg there was a partial symptomatic response. CONCLUSIONS: Antidepressant withdrawal manic states are an under-recognized phenomena, with ill defined patho-physiological pathways and nosology. It is important to continue close follow up of the patient and to investigate whether it can be included on the bipolar spectrum. Cambridge University Press 2021-08-13 /pmc/articles/PMC9528443/ http://dx.doi.org/10.1192/j.eurpsy.2021.543 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
Magalhães, M.
Moreno, L.
Mendes, R.
Gamito, A.
Antidepressant-withdrawal mania - a case report
title Antidepressant-withdrawal mania - a case report
title_full Antidepressant-withdrawal mania - a case report
title_fullStr Antidepressant-withdrawal mania - a case report
title_full_unstemmed Antidepressant-withdrawal mania - a case report
title_short Antidepressant-withdrawal mania - a case report
title_sort antidepressant-withdrawal mania - a case report
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9528443/
http://dx.doi.org/10.1192/j.eurpsy.2021.543
work_keys_str_mv AT magalhaesm antidepressantwithdrawalmaniaacasereport
AT morenol antidepressantwithdrawalmaniaacasereport
AT mendesr antidepressantwithdrawalmaniaacasereport
AT gamitoa antidepressantwithdrawalmaniaacasereport